Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

924
This protocol presents a step-by-step guide for performing minimally invasive isolated limb perfusion (MI-ILP), a treatment option for patients with locally advanced melanomas and sarcomas of the...
924
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

10.2K
In this protocol, we describe a mouse model of incomplete surgical resection of soft tissue sarcoma for testing (neo)adjuvant...
10.2K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

14.9K
The following protocol focuses on the establishment of a primary culture of patient-derived soft tissue sarcoma (STS). This model could help us to better understand the molecular background and pharmacological profile of these rare malignancies and could represent a starting point for further research aimed at improving STS...
14.9K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

9.8K
We present here a cell culture method for inducing mesenchymal-epithelial transitions (MET) in sarcoma cells based on combined ectopic expression of microRNA-200 family members and grainyhead-like 2 (GRHL2). This method is suitable for better understanding the biological impact of phenotypic plasticity on cancer aggressiveness and...
9.8K
The In ovo CAM-assay as a Xenograft Model for Sarcoma12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

26.2K
The in ovo chorioallantoic membrane (CAM) is grafted with fresh sarcoma-derived tumor tissues, their single cell suspensions, and permanent and transient fluorescently labeled established sarcoma cell lines. The model is used to study graft- (viability, Ki67 proliferation index, necrosis, infiltration) and host (fibroblast infiltration, vascular ingrowth)...
26.2K
Isolating Stem Cells from Soft Musculoskeletal Tissues07:49

Isolating Stem Cells from Soft Musculoskeletal Tissues

13.9K
Isolating adult stem cells from musculoskeletal soft tissues based on the cell's adherence speed to...
13.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an intervention to manage knee osteoarthritis risk and symptoms following anterior cruciate ligament injury.

Osteoarthritis and cartilage·2021
Same author

Fundamentals of osteoarthritis: outcome evaluation with patient-reported measures and functional tests.

Osteoarthritis and cartilage·2021
Same author

Immediate outcomes following the GLA:D® program in Denmark, Canada and Australia. A longitudinal analysis including 28,370 patients with symptomatic knee or hip osteoarthritis.

Osteoarthritis and cartilage·2021
Same author

Heating events in the nascent solar system recorded by rare earth element isotopic fractionation in refractory inclusions.

Science advances·2021
Same author

Weight status and associated comorbidities in children and adults with Down syndrome, autism spectrum disorder and intellectual and developmental disabilities.

Journal of intellectual disability research : JIDR·2020
Same author

ON THE RARITY OF NEBULAR MATERIALS WITH SOLAR OXYGEN ISOTOPES.

Proceedings of lunar and planetary science·2019
Same journal

Integrative Medicine for Breast Cancer Survivors.

Seminars in radiation oncology·2026
Same journal

Integrative Oncology Approaches for Gastrointestinal Symptoms and Risk Reduction in Patients With Digestive Tract Cancers.

Seminars in radiation oncology·2026
Same journal

Integrative Oncology and Radiation Therapy: An Essential Evolution.

Seminars in radiation oncology·2026
Same journal

Clinical Trials of Integrative Oncology Interventions for Radiation Therapy: Emerging Evidence and Opportunities.

Seminars in radiation oncology·2026
Same journal

Nonpharmacologic Approaches for Pain Management in Patients With Cancer Treated With Radiation Therapy.

Seminars in radiation oncology·2026
Same journal

Integrative Therapies for Radiation-Related Toxicities in Hematological Malignancies.

Seminars in radiation oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

924

Functional outcome in extremity soft tissue sarcoma.

A M Davis1

  • 1Departments of Physical Therapy and Surgery, Mount Sinai Hospital, Toronto, Canada.

Seminars in Radiation Oncology
|October 12, 1999
PubMed
Summary
This summary is machine-generated.

Functional outcomes after limb preservation surgery for extremity soft tissue sarcoma (STS) are often measured by impairments. While 50% of patients experience impairments, disability is less frequent, necessitating standardized outcome measures for better patient results.

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.9K

Related Experiment Videos

Last Updated: Jan 19, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

924
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.9K

Area of Science:

  • Orthopedic Surgery
  • Oncology
  • Rehabilitation Medicine

Background:

  • Limb preservation surgery is a key treatment for extremity soft tissue sarcoma (STS).
  • Functional outcomes are crucial for assessing treatment success in STS patients.
  • Current literature primarily focuses on impairments rather than broader disability measures.

Purpose of the Study:

  • To review and synthesize the literature on functional outcomes following limb preservation surgery for STS.
  • To identify the prevalence of impairments and disabilities in these patients.
  • To highlight the need for standardized outcome measures in future research.

Main Methods:

  • Systematic review of studies reporting functional outcomes in patients with extremity soft tissue sarcoma.
  • Analysis of evaluated functional domains, including impairments (e.g., range of motion, strength) and disabilities (e.g., daily living activities, mobility).
  • Assessment of study heterogeneity in patient samples, treatments, and outcome measures.

Main Results:

  • Approximately 50% of patients treated for STS experience significant impairments.
  • Disability, encompassing daily living activities and mobility, is less frequently reported than impairments.
  • Significant heterogeneity exists in study methodologies and outcome assessments, hindering result synthesis.

Conclusions:

  • Standardized definitions and validated functional outcome measures are essential for future STS research.
  • Understanding the determinants of functional outcomes is critical for developing targeted interventions.
  • Improved patient functional outcomes depend on consistent evaluation and tailored interventions.